Clinical Trial Update: G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing G-Pen to Lilly glucagon for hypoglycemia rescue in adults with type 1 diabetes has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• G-Pen (glucagon)
• Lilly Glucagon (glucagon)

Snippet

Sponsor: Xeris Pharmaceuticals | Conditions: Insulin Hypoglycemia, Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2019-05-30